259 related articles for article (PubMed ID: 6798764)
1. [Hypophyseal reaction state during oral contraceptiva (author's transl)].
Gitsch E; Schneider WH; Schmid R; Spona J
Wien Klin Wochenschr; 1981 Oct; 93(19):599-601. PubMed ID: 6798764
[TBL] [Abstract][Full Text] [Related]
2. [The efficacy of gestoden (delta 15-d-norgestrel) as ovulation inhibitor (author's transl)].
Schneider WH; Schmid R; Spona J
Wien Klin Wochenschr; 1981 Oct; 93(19):601-4. PubMed ID: 6798765
[TBL] [Abstract][Full Text] [Related]
3. The effect of deliberate omission of Trinordiol or Microgynon on the hypothalamo-pituitary-ovarian axis.
Smith SK; Kirkman RJ; Arce BB; McNeilly AS; Loudon NB; Baird DT
Contraception; 1986 Nov; 34(5):513-22. PubMed ID: 3102162
[TBL] [Abstract][Full Text] [Related]
4. [Plasma concentrations of LH and of sex steroids during the normal menstrual cycle and during contraceptive treatment].
Bayard F; Louvet JP; Moatti JP; Smilovici W; Duguet L; Boulard C
J Gynecol Obstet Biol Reprod (Paris); 1975; 4(7):915-26. PubMed ID: 767402
[TBL] [Abstract][Full Text] [Related]
5. [The effect of oral ovulation inhibiting (mono-, bi- and triphase) contraceptives and of Continuin and Postinor on proteo- and steroid hormones].
Farkas M
Acta Pharm Hung; 1992; 62(1-2):17-30. PubMed ID: 1566635
[TBL] [Abstract][Full Text] [Related]
6. Metabolic profile of six oral contraceptives containing norgestimate, gestodene, and desogestrel.
Teichmann A
Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():98-104. PubMed ID: 8574257
[TBL] [Abstract][Full Text] [Related]
7. Pulsatile luteinizing hormone patterns in long term oral contraceptive users.
Hemrika DJ; Slaats EH; Kennedy JC; de Vries Robles-Korsen TJ; Schoemaker J
J Clin Endocrinol Metab; 1993 Aug; 77(2):420-6. PubMed ID: 8345046
[TBL] [Abstract][Full Text] [Related]
8. [The effect of different types of oral contraceptives upon ovarian function (author's transl)].
Aktories K; Krög W; Dericks-Tan JS; Jürgensen O; Taubert HD
Geburtshilfe Frauenheilkd; 1976 Apr; 36(4):318-26. PubMed ID: 1269893
[TBL] [Abstract][Full Text] [Related]
9. Oral contraceptives.
Maclennan AH
Curr Ther (Seaforth); 1987 Dec; 28(12):113-22. PubMed ID: 12317413
[TBL] [Abstract][Full Text] [Related]
10. Comparative studies of the ethynyl estrogens used in oral contraceptives. III. Effect on plasma gonadotropins.
Goldzieher JW; de la Peña A; Chenault CB; Cervantes A
Am J Obstet Gynecol; 1975 Jul; 122(5):625-36. PubMed ID: 1146928
[TBL] [Abstract][Full Text] [Related]
11. [Influence of progestins on adverse effects of oral contraceptives].
Wynn V
Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):425-30. PubMed ID: 12280210
[TBL] [Abstract][Full Text] [Related]
12. [Comparison of the sebaceous secretions of the skin of the forehead under the treatment with three oral contraceptives. Diane, Neogynon and Lyndiol (author's transl)].
Leis D; Clarin A
Geburtshilfe Frauenheilkd; 1979 Jan; 39(1):54-7. PubMed ID: 422029
[TBL] [Abstract][Full Text] [Related]
13. Pituitary and ovarian function in women receiving hormonal contraception.
Cohen BL; Katz M
Contraception; 1979 Nov; 20(5):475-87. PubMed ID: 393456
[TBL] [Abstract][Full Text] [Related]
14. Serum levels of FSH, LH, estradiol-17 beta and progesterone following the administration of a combined oral contraceptive containing 20 micrograms ethinylestradiol.
Carlström K; Lunell NO; Zador G
Gynecol Obstet Invest; 1978; 9(6):304-11. PubMed ID: 754992
[TBL] [Abstract][Full Text] [Related]
15. A randomized cross-over comparison of two low-dose oral contraceptives upon hormonal and metabolic parameters: I. Effects upon sexual hormone levels.
Kuhl H; Gahn G; Romberg G; März W; Taubert HD
Contraception; 1985 Jun; 31(6):583-93. PubMed ID: 2931247
[TBL] [Abstract][Full Text] [Related]
16. [Comparative biochemical investigations with contraceptives at different dose levels (author's transl)].
Werner-Zodrow I; Mall-Häfeli M; Uettwiller A
Geburtshilfe Frauenheilkd; 1979 Jul; 39(7):558-63. PubMed ID: 467947
[TBL] [Abstract][Full Text] [Related]
17. [Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives].
Cianci A; De Leo V
Minerva Ginecol; 2007 Aug; 59(4):415-25. PubMed ID: 17923832
[TBL] [Abstract][Full Text] [Related]
18. Clinical experience of a combined oral contraceptive with very low dose ethinyl estradiol.
Akerlund M
Acta Obstet Gynecol Scand Suppl; 1997; 164():63-5. PubMed ID: 9225641
[TBL] [Abstract][Full Text] [Related]
19. [Oral contraceptives and blood platelets].
Davenas E; Ciavatti M; Poitevin B; Aubin M
Homeopath Fr; 1985; 73(5):299-305. PubMed ID: 12281246
[TBL] [Abstract][Full Text] [Related]
20. [Pharmacodynamics of synthetic estrogens. Review article].
Sojo-Aranda I; Cortés-Gallegos V
Ginecol Obstet Mex; 1990 Oct; 58():277-83. PubMed ID: 2292429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
